Even as the EU and India continue negotiations on a free trade agreement ahead of their next summit in February, another in transit consignment of Indian generics was seized in the EU late last year, much to the consternation of both the Indian ...
The acceptance by the European court of justice of supplementary protection certificates having non-positive terms is welcome news for the innovative pharmaceutical industry, says Mike Snodin. In July 2007, in a predecessor publication to Scrip ...
Multinationals including Bayer and Pfizer appear to have got the ball rolling towards working out compensation payable for clinical trial-related deaths in India, though the absence of "finalised" guidelines on such compensation may be slowing down ...
Pfizer has finally concluded its long-running legal battle over its controversial 1996 Trovan clinical trial, which was conducted during a meningitis epidemic in Nigeria, and involved about 200 children, where allegedly many suffered serious injury ...
Maria Isabel Manley and Maria Georgiou consider the implications of the Office of Fair Trading decision in the Reckitt case on lifecycle management strategies and abuse of dominant position. On 20 September, the UK's Office of Fair Trading published ...
Draft European guidance on the kind of information that can be released from drug approval dossiers has received a predictably mixed response from pharmaceutical industry and public interest bodies 1 ,2 . Industry groups are concerned that ...
